Overview

Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin or Carboplatin

Status:
Unknown status

Trial end date:
2020-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to find out if the combination of trans-arterial chemoembolization (LC or ONCOZENE BEAD) plus infusional chemotherapy is safe and more effective than just receiving the infusional chemotherapy alone.

Phase:

Phase 2

Details

Lead Sponsor:

Robert C. Martin
University of Louisville

Collaborator:

University of Louisville

Treatments:

Carboplatin
Cisplatin
Gemcitabine
Irinotecan